Amgen

News

Roche's blockbuster breast cancer drug Herceptin

FDA approves Herceptin biosimilar as US patent expires

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry.

News

Amgen offers $167m for drug discovery biotech Nuevolution

Amgen has agreed to buy Swedish biotech Nuevolution for around $167 million to boost its drug pipeline after an R&D collaboration showed promise.

Partner Content

Partner Content

Hear from Amgen speaking at the 4th Pre-filled Syringes West...

Pre-filled Syringes WC - workshop

News

At long last, Amgen/UCB score FDA okay for Evenity

Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down by the regulator because of safety concerns.

Events

Partner Content

3rd annual Advanced R&D Sourcing & Procurement Summit 2019

Discover Preclinical R&D

News

Novartis sues as Amgen tries to cancel migraine tie-up

Novartis and Amgen have become embroiled in a legal row over rights to the migraine prevention drug Aimovig, as sales of a new class of injected drugs begin to mount.

FDA approves Herceptin biosimilar as US patent expires

Amgen offers $167m for drug discovery biotech Nuevolution

Hear from Amgen speaking at the 4th Pre-filled Syringes West...

At long last, Amgen/UCB score FDA okay for Evenity

3rd annual Advanced R&D Sourcing & Procurement Summit 2019

Novartis sues as Amgen tries to cancel migraine tie-up

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

Amgen

Editor's Picks